Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I E Johnson

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The Prostate|January 1, 1990
Changes in tumor characteristics during progression of the R3327 HI experimental prostatic carcinomaB G Mobbs, I E Johnson
The Journal of Steroid Biochemistry and Molecular Biology|November 1, 1991
Suppression of the growth of the androgen-insensitive R3327 HI rat prostatic carcinoma by combined estrogen and antiprogestin treatmentB G Mobbs, I E Johnson
The Prostate|January 1, 1986
Quantitative relationships between cytosol and nuclear estrogen and progesterone receptors in the R3327 prostatic carcinoma of rats treated with diethylstilbestrolB G Mobbs, I E Johnson
Journal of Steroid Biochemistry|December 1, 1987
Use of an enzymeimmunoassay (EIA) for quantitation of cytosolic and nuclear estrogen receptor, and correlation with progesterone receptor in human breast cancerB G Mobbs, I E Johnson
Canadian Medical Association Journal|February 7, 1976
In vitro estrogen-binding by human breast carcinomasB G Mobbs, I E Johnson
Journal of Steroid Biochemistry|January 1, 1985
Characterization of estrogen-induced progestin binding in cytosol of the R3327 prostatic carcinoma of the ratB G Mobbs, I E Johnson
Cancer Research|June 1, 1988
Basal and estrogen-stimulated hormone receptor profiles in four R3327 rat prostatic carcinoma sublines in relation to histopathology and androgen sensitivityB G Mobbs, I E Johnson
The Prostate|January 1, 1990
Quantitation of cytosolic and nuclear estrogen and progesterone receptor in benign, untreated, and treated malignant human prostatic tissue by radioligand binding and enzyme-immunoassaysB G Mobbs, I E Johnson, Y Liu
The Prostate|January 1, 1980
The effect of therapy on the concentration and occupancy of androgen receptors in human prostatic cytosolB G Mobbs, I E Johnson, J G Connolly
Journal of Steroid Biochemistry|September 1, 1983
Concentration and cellular distribution of androgen receptor in human prostatic neoplasia: can estrogen treatment increase androgen receptor content?B G Mobbs, I E Johnson, J G Connolly, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Prostate|January 1, 1990
Changes in tumor characteristics during progression of the R3327 HI experimental prostatic carcinomaB G Mobbs, I E Johnson
The Journal of Steroid Biochemistry and Molecular Biology|November 1, 1991
Suppression of the growth of the androgen-insensitive R3327 HI rat prostatic carcinoma by combined estrogen and antiprogestin treatmentB G Mobbs, I E Johnson
The Prostate|January 1, 1986
Quantitative relationships between cytosol and nuclear estrogen and progesterone receptors in the R3327 prostatic carcinoma of rats treated with diethylstilbestrolB G Mobbs, I E Johnson
Journal of Steroid Biochemistry|December 1, 1987
Use of an enzymeimmunoassay (EIA) for quantitation of cytosolic and nuclear estrogen receptor, and correlation with progesterone receptor in human breast cancerB G Mobbs, I E Johnson
Canadian Medical Association Journal|February 7, 1976
In vitro estrogen-binding by human breast carcinomasB G Mobbs, I E Johnson
Journal of Steroid Biochemistry|January 1, 1985
Characterization of estrogen-induced progestin binding in cytosol of the R3327 prostatic carcinoma of the ratB G Mobbs, I E Johnson
Cancer Research|June 1, 1988
Basal and estrogen-stimulated hormone receptor profiles in four R3327 rat prostatic carcinoma sublines in relation to histopathology and androgen sensitivityB G Mobbs, I E Johnson
The Prostate|January 1, 1990
Quantitation of cytosolic and nuclear estrogen and progesterone receptor in benign, untreated, and treated malignant human prostatic tissue by radioligand binding and enzyme-immunoassaysB G Mobbs, I E Johnson, Y Liu
The Prostate|January 1, 1980
The effect of therapy on the concentration and occupancy of androgen receptors in human prostatic cytosolB G Mobbs, I E Johnson, J G Connolly
Journal of Steroid Biochemistry|September 1, 1983
Concentration and cellular distribution of androgen receptor in human prostatic neoplasia: can estrogen treatment increase androgen receptor content?B G Mobbs, I E Johnson, J G Connolly, et al.
Pageof 2